Autor: "Ma N" - OpacWWW - Prolib Integro

Skocz do pozycji: 1 1.

Tytuł :: Triple artemisinin-based combination therapies for malaria: proceed with caution.
Autorzy :: Wang J; Central People's Hospital of Zhanjiang, Zhanjiang, Guangdong, China; Artemisinin Research Center and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100070, China.
Xu C; Central People's Hospital of Zhanjiang, Zhanjiang, Guangdong, China; Artemisinin Research Center and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100070, China.
Wong YK; Artemisinin Research Center and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100070, China.
Ma N; Artemisinin Research Center and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100070, China.
Liao FL; Artemisinin Research Center and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100070, China.
Jiang T; Artemisinin Research Center and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100070, China.
Tu Y; Artemisinin Research Center and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100070, China. Electronic address: .; Pokaż więcej
Źródło :: Lancet (London, England) [Lancet] 2021 Dec 19; Vol. 396 (10267), pp. 1976.
Typ publikacji :: Letter
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: Fine tuning of medium chain fatty acids levels increases fruity ester production during alcoholic fermentation.
Autorzy :: Kong CL; College of Enology, Northwest A&F University, Yangling, Shaanxi 712100, China.
Ma N; College of Enology, Northwest A&F University, Yangling, Shaanxi 712100, China.
Yin J; College of Enology, Northwest A&F University, Yangling, Shaanxi 712100, China.
Zhao HY; College of Enology, Northwest A&F University, Yangling, Shaanxi 712100, China.
Tao YS; College of Enology, Northwest A&F University, Yangling, Shaanxi 712100, China; Shaanxi Engineering Research Center for Viti-viniculture, Yangling, Shaanxi 712100, China. Electronic address: .; Pokaż więcej
Źródło :: Food chemistry [Food Chem] 2021 Jun 01; Vol. 346, pp. 128897. Date of Electronic Publication: 2021 Jan 03.
Typ publikacji :: Journal Article
MeSH Terms :: Fermentation*
Esters/*chemistry
Esters/*metabolism
Fatty Acids/*metabolism
Fruit/chemistry ; Pichia/metabolism ; Saccharomyces cerevisiae/metabolism ; Taste ; Vitis/chemistry ; Vitis/microbiology ; Wine/analysis
SCR Organism :: Pichia fermentans
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: Enolase-specific cross antibodies induce neutrophilic inflammation in the intestine.
Autorzy :: Lin J; Research Center of Allergy & Immunology, Shenzhen University School of Medicine, Shenzhen, China.
Feng BS; Department of Gastroenterology, Second Affiliated Hospital, Zhengzhou University, Zhengzhou, China.
Huang N; Research Center of Allergy & Immunology, Shenzhen University School of Medicine, Shenzhen, China.
Ma N; Department of Gastroenterology, Second Affiliated Hospital, Zhengzhou University, Zhengzhou, China.
Liu ZQ; Longgang ENT Hospital & Shenzhen ENT Institute, Shenzhen, China.
Shu Q; Department of Gastroenterology, First Affiliated Hospital, Shenzhen University, Shenzhen, China.
Zhong N; State Key Laboratory of Respiratory Disease, National Clinical Center for Respiratory Diseases, Guangzhou Institute of Respiratory Diseases, First Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Liu ZG; Research Center of Allergy & Immunology, Shenzhen University School of Medicine, Shenzhen, China.
Yang PC; Research Center of Allergy & Immunology, Shenzhen University School of Medicine, Shenzhen, China.; Guangdong Provincial Key Laboratory of Regional Immunity and Diseases, Shenzhen, China.; Pokaż więcej
Źródło :: Journal of leukocyte biology [J Leukoc Biol] 2021 Mar; Vol. 109 (3), pp. 633-644. Date of Electronic Publication: 2020 Aug 18.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: miR‑93‑5p regulates the occurrence and development of esophageal carcinoma epithelial cells by targeting TGFβR2.
Autorzy :: Cai Y; Department of Thoracic Surgery, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, P.R. China.
Ruan W; Department of Thoracic Surgery, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, P.R. China.
Ding J; Department of Radiotherapy, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, P.R. China.
Wei N; Department of Chest Radiotherapy, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, P.R. China.
Wang J; Department of Pathology, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, P.R. China.
Zhang H; Department of Thoracic Surgery, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, P.R. China.
Ma N; Department of Radiotherapy, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, P.R. China.
Weng G; Department of Thoracic Surgery, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, P.R. China.
Su WK; Department of Thoracic Surgery, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, P.R. China.
Lin Y; Department of Thoracic Surgery, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, P.R. China.
Zhu K; Department of Thoracic Surgery, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, P.R. China.; Pokaż więcej
Źródło :: International journal of molecular medicine [Int J Mol Med] 2021 Mar; Vol. 47 (3). Date of Electronic Publication: 2021 Jan 15.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Metabolites of microbiota response to tryptophan and intestinal mucosal immunity: A therapeutic target to control intestinal inflammation.
Autorzy :: Zhang J; State Key Laboratory of Animal Nutrition, College of Animal Science and Technology, China Agricultural University, Beijing, China.; Animal Husbandry and Veterinary Department, Beijing Vocational College of Agriculture, Beijing, China.
Zhu S; Institute of Botany, Key laboratory of plant molecular physiology, Chinese Academy of Sciences, Beijing, China.
Ma N; State Key Laboratory of Animal Nutrition, College of Animal Science and Technology, China Agricultural University, Beijing, China.
Johnston LJ; West Central Research and Outreach Center, University of Minnesota, Morris, Minnesota, USA.
Wu C; Department of Nutrition and Food Science, Texas A&M University, College Station, Texas, USA.
Ma X; State Key Laboratory of Animal Nutrition, College of Animal Science and Technology, China Agricultural University, Beijing, China.; Pokaż więcej
Źródło :: Medicinal research reviews [Med Res Rev] 2021 Mar; Vol. 41 (2), pp. 1061-1088. Date of Electronic Publication: 2020 Nov 10.
Typ publikacji :: Journal Article; Review
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: Adverse Outcomes Associated With Higher Mean Blood Pressure and Greater Blood Pressure Variability Immediately After Successful Embolectomy in Those With Acute Ischemic Stroke, and the Influence of Pretreatment Collateral Circulation Status.
Autorzy :: Liu D; Department of Neurology Beijing Tiantan HospitalCapital Medical University Beijing China.; China National Clinical Research Center for Neurological Diseases Beijing China.
Nie X; Department of Neurology Beijing Tiantan HospitalCapital Medical University Beijing China.; China National Clinical Research Center for Neurological Diseases Beijing China.
Pan Y; Department of Neurology Beijing Tiantan HospitalCapital Medical University Beijing China.; China National Clinical Research Center for Neurological Diseases Beijing China.
Yan H; China National Clinical Research Center for Neurological Diseases Beijing China.
Pu Y; Department of Neurology Beijing Tiantan HospitalCapital Medical University Beijing China.; China National Clinical Research Center for Neurological Diseases Beijing China.
Wei Y; Department of Neurology Beijing Tiantan HospitalCapital Medical University Beijing China.; China National Clinical Research Center for Neurological Diseases Beijing China.
Cai Y; Department of Neurology Beijing Tiantan HospitalCapital Medical University Beijing China.; China National Clinical Research Center for Neurological Diseases Beijing China.
Ding Y; Department of Neurology Beijing Tiantan HospitalCapital Medical University Beijing China.; China National Clinical Research Center for Neurological Diseases Beijing China.
Lu Q; Department of Neurology Beijing Tiantan HospitalCapital Medical University Beijing China.; China National Clinical Research Center for Neurological Diseases Beijing China.
Zhang Z; Department of Neurology Beijing Tiantan HospitalCapital Medical University Beijing China.; China National Clinical Research Center for Neurological Diseases Beijing China.
Gu W; Department of Radiology Beijing Tiantan HospitalCapital Medical University Beijing China.
Hou X; Department of Radiology Beijing Tiantan HospitalCapital Medical University Beijing China.
Yang Z; Department of Neurology Beijing Tiantan HospitalCapital Medical University Beijing China.; China National Clinical Research Center for Neurological Diseases Beijing China.
Wen M; Department of Neurology Beijing Tiantan HospitalCapital Medical University Beijing China.; China National Clinical Research Center for Neurological Diseases Beijing China.
Wang P; Department of Neurology Beijing Tiantan HospitalCapital Medical University Beijing China.; China National Clinical Research Center for Neurological Diseases Beijing China.
Ma G; Department of Interventional Neurology Beijing Tiantan HospitalCapital Medical University Beijing China.
Ma N; Department of Interventional Neurology Beijing Tiantan HospitalCapital Medical University Beijing China.
Miao Z; Department of Interventional Neurology Beijing Tiantan HospitalCapital Medical University Beijing China.
Leng X; Department of Medicine and Therapeutics, Prince of Wales Hospital Chinese University of Hong Kong Hong Kong SAR China.
Yan B; Department of Medicine and Neurology Melbourne Brain Centre at the Royal Melbourne HospitalUniversity of Melbourne Parkville Victoria Australia.
Davis SM; Department of Medicine and Neurology Melbourne Brain Centre at the Royal Melbourne HospitalUniversity of Melbourne Parkville Victoria Australia.
Wang Y; Department of Neurology Beijing Tiantan HospitalCapital Medical University Beijing China.; China National Clinical Research Center for Neurological Diseases Beijing China.
Liu L; Department of Neurology Beijing Tiantan HospitalCapital Medical University Beijing China.; China National Clinical Research Center for Neurological Diseases Beijing China.; Pokaż więcej
Źródło :: Journal of the American Heart Association [J Am Heart Assoc] 2021 Feb 26, pp. e019350. Date of Electronic Publication: 2021 Feb 26.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: Integrated CNV-seq, karyotyping and SNP-array analyses for effective prenatal diagnosis of chromosomal mosaicism.
Autorzy :: Ma N; Department of Medical Genetics, Hunan Provincial Maternal and Child Health Care Hospital, Changsha, 410008, Hunan, China.
Xi H; Department of Medical Genetics, Hunan Provincial Maternal and Child Health Care Hospital, Changsha, 410008, Hunan, China.
Chen J; Department of Medical Genetics, Hunan Provincial Maternal and Child Health Care Hospital, Changsha, 410008, Hunan, China.
Peng Y; Department of Medical Genetics, Hunan Provincial Maternal and Child Health Care Hospital, Changsha, 410008, Hunan, China.
Jia Z; Department of Medical Genetics, Hunan Provincial Maternal and Child Health Care Hospital, Changsha, 410008, Hunan, China.
Yang S; Department of Medical Genetics, Hunan Provincial Maternal and Child Health Care Hospital, Changsha, 410008, Hunan, China.
Hu J; Department of Medical Genetics, Hunan Provincial Maternal and Child Health Care Hospital, Changsha, 410008, Hunan, China.
Pang J; Department of Medical Genetics, Hunan Provincial Maternal and Child Health Care Hospital, Changsha, 410008, Hunan, China.
Zhang Y; Department of Medical Genetics, Hunan Provincial Maternal and Child Health Care Hospital, Changsha, 410008, Hunan, China.
Hu R; Department of Medical Genetics, Hunan Provincial Maternal and Child Health Care Hospital, Changsha, 410008, Hunan, China.
Wang H; Department of Medical Genetics, Hunan Provincial Maternal and Child Health Care Hospital, Changsha, 410008, Hunan, China. .; National Health Commission Key Laboratory of Birth Defects Research, Prevention and Treatment, Changsha, 410008, Hunan, China. .
Liu J; Department of Medical Genetics, Hunan Provincial Maternal and Child Health Care Hospital, Changsha, 410008, Hunan, China. .; Pokaż więcej
Źródło :: BMC medical genomics [BMC Med Genomics] 2021 Feb 25; Vol. 14 (1), pp. 56. Date of Electronic Publication: 2021 Feb 25.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: Protectin D1 decreases pancreatitis severity in mice by inhibiting neutrophil extracellular trap formation.
Autorzy :: Wu Z; Department of Critical Care Medicine, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, 758 Hefei Road, Qingdao, Shandong 266035, China.
Lu G; Department of Gastroenterology, Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, Jiangsu, China.
Zhang L; Department of Pathology, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, 210023 Nanjing, China.
Ke L; Department of Critical Care Medicine, PLA Key Laboratory of Emergency and Critical Care Research, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China.
Yuan C; Department of Critical Care Medicine, PLA Key Laboratory of Emergency and Critical Care Research, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China.
Ma N; Department of Critical Care Medicine, PLA Key Laboratory of Emergency and Critical Care Research, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China.
Yu X; Department of Critical Care Medicine, PLA Key Laboratory of Emergency and Critical Care Research, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China.
Guo X; Department of Critical Care Medicine, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, 758 Hefei Road, Qingdao, Shandong 266035, China.
Zhao W; Department of Critical Care Medicine, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, 758 Hefei Road, Qingdao, Shandong 266035, China.
Wang Y; Department of Critical Care Medicine, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, 758 Hefei Road, Qingdao, Shandong 266035, China.
Hu S; Department of General Surgery, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Wu D; Department of Critical Care Medicine, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, 758 Hefei Road, Qingdao, Shandong 266035, China. Electronic address: .
Li W; Department of Critical Care Medicine, PLA Key Laboratory of Emergency and Critical Care Research, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China. Electronic address: .; Pokaż więcej
Źródło :: International immunopharmacology [Int Immunopharmacol] 2021 Feb 24; Vol. 94, pp. 107486. Date of Electronic Publication: 2021 Feb 24.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: CM082, a novel VEGF receptor tyrosine kinase inhibitor, can inhibit angiogenesis in vitro and in vivo.
Autorzy :: Dan H; Henan Eye Institute, Henan Eye Hospital, Henan Key Laboratory of Ophthalmology and Visual Science, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, No. 7 Weiwu Road, Zhengzhou 450000, Henan, China.
Lei X; Eye Center, Renmin Hospital of Wuhan University, No. 99 ZhangZhiDong Road, Wuhan 430060, Hubei, China.
Huang X; Eye Center, Renmin Hospital of Wuhan University, No. 99 ZhangZhiDong Road, Wuhan 430060, Hubei, China.
Ma N; Eye Center, Renmin Hospital of Wuhan University, No. 99 ZhangZhiDong Road, Wuhan 430060, Hubei, China.
Xing Y; Eye Center, Renmin Hospital of Wuhan University, No. 99 ZhangZhiDong Road, Wuhan 430060, Hubei, China.
Shen Y; Eye Center, Renmin Hospital of Wuhan University, No. 99 ZhangZhiDong Road, Wuhan 430060, Hubei, China. Electronic address: .; Pokaż więcej
Źródło :: Microvascular research [Microvasc Res] 2021 Feb 19; Vol. 136, pp. 104146. Date of Electronic Publication: 2021 Feb 19.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Primary observation of the role of posttranslational modification of dentin sialophosphoprotein (DSPP) on postnatal development of mandibular condyle in mice.
Autorzy :: Ye J; Department of Oral and Maxillofacial Surgery, Hospital of Stomatology, Jilin University, Changchun, China; Jilin Provincial Key Laboratory of Tooth Development and Bone Remodeling, School and Hospital of Stomatology, Jilin University, Changchun, China.
Wang Y; Department of Oral and Maxillofacial Surgery, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, China.
Zhu Q; State Key Laboratory of Military Stomatology and National Clinical Research Center for Oral Diseases and Shaanxi Key Laboratory of Stomatology, Department of Operative Dentistry and Endodontics, School of Stomatology, The Fourth Military Medical University, Xi'an, China.
Shi H; Department of Oral and Maxillofacial Surgery, Hospital of Stomatology, Jilin University, Changchun, China; Jilin Provincial Key Laboratory of Tooth Development and Bone Remodeling, School and Hospital of Stomatology, Jilin University, Changchun, China.
Xiang D; Department of Oral and Maxillofacial Surgery, Hospital of Stomatology, Jilin University, Changchun, China; Jilin Provincial Key Laboratory of Tooth Development and Bone Remodeling, School and Hospital of Stomatology, Jilin University, Changchun, China.
Wu C; Department of Oral and Maxillofacial Surgery, Hospital of Stomatology, Jilin University, Changchun, China; Jilin Provincial Key Laboratory of Tooth Development and Bone Remodeling, School and Hospital of Stomatology, Jilin University, Changchun, China.
Song L; Department of Oral and Maxillofacial Surgery, Hospital of Stomatology, Jilin University, Changchun, China; Jilin Provincial Key Laboratory of Tooth Development and Bone Remodeling, School and Hospital of Stomatology, Jilin University, Changchun, China.
Ma N; Department of Rheumatology, The First Hospital, Jilin University, Changchun, China.
Liu Q; Department of Oral and Maxillofacial Surgery, Hospital of Stomatology, Jilin University, Changchun, China; Jilin Provincial Key Laboratory of Tooth Development and Bone Remodeling, School and Hospital of Stomatology, Jilin University, Changchun, China. Electronic address: .
Zhang W; Department of Oral and Maxillofacial Surgery, Hospital of Stomatology, Jilin University, Changchun, China. Electronic address: .; Pokaż więcej
Źródło :: Archives of oral biology [Arch Oral Biol] 2021 Feb 18; Vol. 125, pp. 105086. Date of Electronic Publication: 2021 Feb 18.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Protective role for collectin-11 in rheumatoid arthritis in mice.
Autorzy :: Wang N; Core Research Laboratory, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
Wu W; Peter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, Faculty of Life Sciences & Medicine, King's College London, UK, London.
Qiang C; Key Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, College of Stomatology, Xi'an Jiaotong University, Xi'an, China.
Ma N; Core Research Laboratory, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
Wu K; Core Research Laboratory, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
Liu D; Department of Rheumatology and Immunology, Xi'an No. 5 Hospital, Xi'an, China.
Wang JX; Core Research Laboratory, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
Yang X; Core Research Laboratory, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
Xue L; Department of Clinical Laboratory, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
Diao TY; Core Research Laboratory, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
Liu JY; Department of Rheumatology and Immunology, Xi'an No. 5 Hospital, Xi'an, China.
Li A; Key Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, College of Stomatology, Xi'an Jiaotong University, Xi'an, China.
Zhang B; Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an, China.
Li ZF; National Local Joint Engineering Research Centre of Biodiagnostics and Biotherapy, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
Farrar CA; Peter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, Faculty of Life Sciences & Medicine, King's College London, UK, London.
Banda NK; Division of Rheumatology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA.
Bayarri-Olmos R; Laboratory of Molecular Medicine, Department of Clinical Immunology Section, 7631, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
Garred P; Laboratory of Molecular Medicine, Department of Clinical Immunology Section, 7631, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
Zhou W; Peter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, Faculty of Life Sciences & Medicine, King's College London, UK, London.
Li K; Core Research Laboratory, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.; National Local Joint Engineering Research Centre of Biodiagnostics and Biotherapy, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.; Pokaż więcej
Źródło :: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2021 Feb 18. Date of Electronic Publication: 2021 Feb 18.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Current Status of Endovascular Treatment for Acute Large Vessel Occlusion in China: A Real-World Nationwide Registry.
Autorzy :: Jia B; Interventional Neuroradiology Center, Beijing Tiantan Hospital, Capital Medical University. (B.J., D.M., N.M., F.G., X.H., G.L., L.S., X.S., X.Z., G.P., J. Zhang, K.Z., S.L., Z.Q., H.X., X.T., G.M., R.L., Y.D., Z.M.).
Ren Z; Department of Neurosurgery, University of South Florida (Z.R., M.M., W.S.B., C.T.B.).
Mokin M; Department of Neurosurgery, University of South Florida (Z.R., M.M., W.S.B., C.T.B.).
Burgin WS; Department of Neurosurgery, University of South Florida (Z.R., M.M., W.S.B., C.T.B.).
Bauer CT; Department of Neurosurgery, University of South Florida (Z.R., M.M., W.S.B., C.T.B.).
Fiehler J; Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Germany (J.F.).
Mo D; Interventional Neuroradiology Center, Beijing Tiantan Hospital, Capital Medical University. (B.J., D.M., N.M., F.G., X.H., G.L., L.S., X.S., X.Z., G.P., J. Zhang, K.Z., S.L., Z.Q., H.X., X.T., G.M., R.L., Y.D., Z.M.).
Ma N; Interventional Neuroradiology Center, Beijing Tiantan Hospital, Capital Medical University. (B.J., D.M., N.M., F.G., X.H., G.L., L.S., X.S., X.Z., G.P., J. Zhang, K.Z., S.L., Z.Q., H.X., X.T., G.M., R.L., Y.D., Z.M.).
Gao F; Interventional Neuroradiology Center, Beijing Tiantan Hospital, Capital Medical University. (B.J., D.M., N.M., F.G., X.H., G.L., L.S., X.S., X.Z., G.P., J. Zhang, K.Z., S.L., Z.Q., H.X., X.T., G.M., R.L., Y.D., Z.M.).
Huo X; Interventional Neuroradiology Center, Beijing Tiantan Hospital, Capital Medical University. (B.J., D.M., N.M., F.G., X.H., G.L., L.S., X.S., X.Z., G.P., J. Zhang, K.Z., S.L., Z.Q., H.X., X.T., G.M., R.L., Y.D., Z.M.).
Luo G; Interventional Neuroradiology Center, Beijing Tiantan Hospital, Capital Medical University. (B.J., D.M., N.M., F.G., X.H., G.L., L.S., X.S., X.Z., G.P., J. Zhang, K.Z., S.L., Z.Q., H.X., X.T., G.M., R.L., Y.D., Z.M.).
Wang A; China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University. (A.W., Y. Pan).
Pan Y; China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University. (A.W., Y. Pan).
Song L; Interventional Neuroradiology Center, Beijing Tiantan Hospital, Capital Medical University. (B.J., D.M., N.M., F.G., X.H., G.L., L.S., X.S., X.Z., G.P., J. Zhang, K.Z., S.L., Z.Q., H.X., X.T., G.M., R.L., Y.D., Z.M.).
Sun X; Interventional Neuroradiology Center, Beijing Tiantan Hospital, Capital Medical University. (B.J., D.M., N.M., F.G., X.H., G.L., L.S., X.S., X.Z., G.P., J. Zhang, K.Z., S.L., Z.Q., H.X., X.T., G.M., R.L., Y.D., Z.M.).
Zhang X; Interventional Neuroradiology Center, Beijing Tiantan Hospital, Capital Medical University. (B.J., D.M., N.M., F.G., X.H., G.L., L.S., X.S., X.Z., G.P., J. Zhang, K.Z., S.L., Z.Q., H.X., X.T., G.M., R.L., Y.D., Z.M.).
Gui L; Department of Interventional Neuroradiology, Langfang Changzheng Hospital, China (L.G.).
Song C; Department of Interventional Neuroradiology, Liaocheng Third People's Hospital, China (C.S.).
Peng Y; Department of Neurosurgery, The First People's Hospital of Changzhou, The Third Affiliated Hospital of Soochow University, China (Y. Peng).
Wu J; Department of Neurology, Second Affiliated Hospital of Nanjing Medical University, China (J.W.).
Zhao S; Department of Interventional Radiology, Fengrun District People's Hospital of Tangshan City, China (S.Z.).
Zhao J; Department of Neurology, SiPing Central People's Hospital, China (J. Zhao).
Zhou Z; Department of Neurology, Yijishan Hospital of Wannan Medical College, China (Z.Z.).
Li Y; Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, China (Y. Li).
Jing P; Department of Neurology, Wuhan Central Hospital, Tongji Medical College, Huazhong University of Science and Technology, China (P.J.).
Yang L; Department of Neurosurgery, The First Hospital of Shijiazhuang, China (L.Y.).
Liu Y; Department of Neurology, Shenzhen Hospital of Southern Medical University, China (Yajie Liu).
Zhao Q; Department of Neurology, The People's Hospital of Longhua, China (Q.Z.).
Liu Y; Department of Neurology, Jingjiang People's Hospital, The Seventh Affiliated Hospital of Yangzhou University, China (Yan Liu).
Peng X; Department of Neurology, Hubei Third People's Hospital, China (X.P.).
Gao Q; Department of Neurology, Institute of Neuroscience, The Second Affiliated Hospital of Guangzhou Medical University, China (Q.G.).
Guo Z; Department of Neurosurgery, Tianjin TEDA Hospital, China (Z.G.).
Chen W; Department of Neurology, Zhangzhou Affiliated Hospital of Fujian Medical University, China (W.C.).
Li W; Department of Neurology, Taiyuan Central Hospital, China (W.L.).
Cheng X; Department of Neurosurgery, The First Affiliated Hospital of Xinjiang Medical University, China (X.C.).
Xu Y; Department of Neurology, Affiliated Drum Tower Hospital of Nanjing University Medical School, China (Y.X.).
Zhang Y; Department of Neurosurgery, Wenling First People's Hospital, China (Y.Z.).
Zhang G; Department of Neurology, The Second Affiliated Hospital of Xi'an Jiaotong University, China (G.Z.).
Lu Y; Department of Internal Neurology, The First People's Hospital of Yulin, China (Y. Lu).
Lu X; Department of Neurosurgery, Zhenjiang First People's Hospital, China (X. Lu).
Wang D; Department of Neurology, Qitaihe Coal General Hospital, China (D.W.).
Wang Y; Stroke Center, People's Hospital of Tangshan City, China (Yan Wang).
Li H; Department of Neurology, Affiliated Hospital Guilin Medical University, China (H.L.).
Ling L; Department of Neurology, The Affiliated Hospital of Hebei University, China (L.L.).
Peng G; Interventional Neuroradiology Center, Beijing Tiantan Hospital, Capital Medical University. (B.J., D.M., N.M., F.G., X.H., G.L., L.S., X.S., X.Z., G.P., J. Zhang, K.Z., S.L., Z.Q., H.X., X.T., G.M., R.L., Y.D., Z.M.).
Zhang J; Interventional Neuroradiology Center, Beijing Tiantan Hospital, Capital Medical University. (B.J., D.M., N.M., F.G., X.H., G.L., L.S., X.S., X.Z., G.P., J. Zhang, K.Z., S.L., Z.Q., H.X., X.T., G.M., R.L., Y.D., Z.M.).
Zhang K; Interventional Neuroradiology Center, Beijing Tiantan Hospital, Capital Medical University. (B.J., D.M., N.M., F.G., X.H., G.L., L.S., X.S., X.Z., G.P., J. Zhang, K.Z., S.L., Z.Q., H.X., X.T., G.M., R.L., Y.D., Z.M.).
Li S; Interventional Neuroradiology Center, Beijing Tiantan Hospital, Capital Medical University. (B.J., D.M., N.M., F.G., X.H., G.L., L.S., X.S., X.Z., G.P., J. Zhang, K.Z., S.L., Z.Q., H.X., X.T., G.M., R.L., Y.D., Z.M.).
Qi Z; Interventional Neuroradiology Center, Beijing Tiantan Hospital, Capital Medical University. (B.J., D.M., N.M., F.G., X.H., G.L., L.S., X.S., X.Z., G.P., J. Zhang, K.Z., S.L., Z.Q., H.X., X.T., G.M., R.L., Y.D., Z.M.).
Xu H; Interventional Neuroradiology Center, Beijing Tiantan Hospital, Capital Medical University. (B.J., D.M., N.M., F.G., X.H., G.L., L.S., X.S., X.Z., G.P., J. Zhang, K.Z., S.L., Z.Q., H.X., X.T., G.M., R.L., Y.D., Z.M.).
Tong X; Interventional Neuroradiology Center, Beijing Tiantan Hospital, Capital Medical University. (B.J., D.M., N.M., F.G., X.H., G.L., L.S., X.S., X.Z., G.P., J. Zhang, K.Z., S.L., Z.Q., H.X., X.T., G.M., R.L., Y.D., Z.M.).
Ma G; Interventional Neuroradiology Center, Beijing Tiantan Hospital, Capital Medical University. (B.J., D.M., N.M., F.G., X.H., G.L., L.S., X.S., X.Z., G.P., J. Zhang, K.Z., S.L., Z.Q., H.X., X.T., G.M., R.L., Y.D., Z.M.).
Liu R; Interventional Neuroradiology Center, Beijing Tiantan Hospital, Capital Medical University. (B.J., D.M., N.M., F.G., X.H., G.L., L.S., X.S., X.Z., G.P., J. Zhang, K.Z., S.L., Z.Q., H.X., X.T., G.M., R.L., Y.D., Z.M.).
Guo X; Department of Neurointervetion, Beijing Anzhen Hospital, Capital Medical University, China (X.G.).
Deng Y; Interventional Neuroradiology Center, Beijing Tiantan Hospital, Capital Medical University. (B.J., D.M., N.M., F.G., X.H., G.L., L.S., X.S., X.Z., G.P., J. Zhang, K.Z., S.L., Z.Q., H.X., X.T., G.M., R.L., Y.D., Z.M.).
Leng X; Department of Medicine and Therapeutics, Chinese University of Hong Kong, China (X. Leng, T.W.L.).
Leung TW; Department of Medicine and Therapeutics, Chinese University of Hong Kong, China (X. Leng, T.W.L.).
Liebeskind DS; Department of Neurology, University of California (D.S.L.).
Wang Y; Department of Neurology, China National Clinical Research Center for Neurological Diseases, Tiantan Clinical Trial and Research Center for Stroke, Beijing Tiantan Hospital, Capital Medical University. (Yilong Wang).
Wang Y; Beijing Tiantan Hospital, Capital Medical University, China (Yongjun Wang).
Miao Z; Interventional Neuroradiology Center, Beijing Tiantan Hospital, Capital Medical University. (B.J., D.M., N.M., F.G., X.H., G.L., L.S., X.S., X.Z., G.P., J. Zhang, K.Z., S.L., Z.Q., H.X., X.T., G.M., R.L., Y.D., Z.M.).; Pokaż więcej
Corporate Authors :: ANGEL-ACT Study Group
Źródło :: Stroke [Stroke] 2021 Feb 18, pp. STROKEAHA120031869. Date of Electronic Publication: 2021 Feb 18.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Potent Bispecific Neutralizing Antibody Targeting Glycoprotein B and the gH/gL/pUL128/130/131 Complex of Human Cytomegalovirus.
Autorzy :: Su H; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, China.; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas, USA.
Ye X; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas, USA.
Freed DC; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA.
Li L; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas, USA.
Ku Z; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas, USA.
Xiong W; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas, USA.
Gao P; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas, USA.
Liu X; University of Houston College of Pharmacy, Houston, Texas, USA.
Montgomery D; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA.
Xu W; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA.
Espeseth AS; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA.
Wang D; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA.
Ma N; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, China .
Fu TM; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas, USA .
Zhang N; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas, USA .
An Z; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas, USA.; Pokaż więcej
Źródło :: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 Feb 17; Vol. 65 (3). Date of Electronic Publication: 2021 Feb 17 (Print Publication: 2021).
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: Biofunction of Polydopamine Coating in Stem Cell Culture.
Autorzy :: Deng Z; Institute of Active Polymers and Berlin-Brandenburg Centre for Regenerative Therapies, Helmholtz-Zentrum Geesthacht, 14513 Teltow, Germany.; Institute of Chemistry and Biochemistry, Free University of Berlin, 14195 Berlin, Germany.
Wang W; Institute of Active Polymers and Berlin-Brandenburg Centre for Regenerative Therapies, Helmholtz-Zentrum Geesthacht, 14513 Teltow, Germany.
Xu X; Institute of Active Polymers and Berlin-Brandenburg Centre for Regenerative Therapies, Helmholtz-Zentrum Geesthacht, 14513 Teltow, Germany.
Nie Y; Institute of Active Polymers and Berlin-Brandenburg Centre for Regenerative Therapies, Helmholtz-Zentrum Geesthacht, 14513 Teltow, Germany.; Institute of Chemistry, University of Potsdam, 14476 Potsdam, Germany.
Liu Y; Institute of Active Polymers and Berlin-Brandenburg Centre for Regenerative Therapies, Helmholtz-Zentrum Geesthacht, 14513 Teltow, Germany.; Institute of Chemistry, University of Potsdam, 14476 Potsdam, Germany.
Gould OEC; Institute of Active Polymers and Berlin-Brandenburg Centre for Regenerative Therapies, Helmholtz-Zentrum Geesthacht, 14513 Teltow, Germany.
Ma N; Institute of Active Polymers and Berlin-Brandenburg Centre for Regenerative Therapies, Helmholtz-Zentrum Geesthacht, 14513 Teltow, Germany.; Institute of Chemistry and Biochemistry, Free University of Berlin, 14195 Berlin, Germany.
Lendlein A; Institute of Active Polymers and Berlin-Brandenburg Centre for Regenerative Therapies, Helmholtz-Zentrum Geesthacht, 14513 Teltow, Germany.; Institute of Chemistry and Biochemistry, Free University of Berlin, 14195 Berlin, Germany.; Institute of Chemistry, University of Potsdam, 14476 Potsdam, Germany.; Pokaż więcej
Źródło :: ACS applied materials & interfaces [ACS Appl Mater Interfaces] 2021 Feb 17. Date of Electronic Publication: 2021 Feb 17.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: Highly sensitive SERS behavior and wavelength-dependence charge transfer effect on the PS/Ag/ZIF-8 substrate.
Autorzy :: Xue X; Key Laboratory of Preparation and Applications of Environmental Friendly Materials (Jilin Normal University), Ministry of Education, Changchun 130103, PR China. Electronic address: .
Chen L; Key Laboratory of Preparation and Applications of Environmental Friendly Materials (Jilin Normal University), Ministry of Education, Changchun 130103, PR China.
Wang C; College of Information & Technology, Jilin Normal University, Siping 136000, PR China.
Zhao C; Key Laboratory of Preparation and Applications of Environmental Friendly Materials (Jilin Normal University), Ministry of Education, Changchun 130103, PR China.
Wang H; Key Laboratory of Preparation and Applications of Environmental Friendly Materials (Jilin Normal University), Ministry of Education, Changchun 130103, PR China.
Ma N; Key Laboratory of Preparation and Applications of Environmental Friendly Materials (Jilin Normal University), Ministry of Education, Changchun 130103, PR China.
Li J; Key Laboratory of Preparation and Applications of Environmental Friendly Materials (Jilin Normal University), Ministry of Education, Changchun 130103, PR China.
Qiao Y; Key Laboratory of Preparation and Applications of Environmental Friendly Materials (Jilin Normal University), Ministry of Education, Changchun 130103, PR China.
Chang L; Key Laboratory of Preparation and Applications of Environmental Friendly Materials (Jilin Normal University), Ministry of Education, Changchun 130103, PR China. Electronic address: .
Zhao B; State Key Laboratory of Supramolecular Structure and Materials, Jilin University, Changchun 130012, PR China. Electronic address: .; Pokaż więcej
Źródło :: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy [Spectrochim Acta A Mol Biomol Spectrosc] 2021 Feb 15; Vol. 247, pp. 119126. Date of Electronic Publication: 2020 Oct 28.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: Cognitive Impairments and Risk Factors After Ruptured Anterior Communicating Artery Aneurysm Treatment in Low-Grade Patients Without Severe Complications: A Multicenter Retrospective Study.
Autorzy :: Ma N; Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; Department of Neurosurgery, The First Hospital of Shanxi Medical University, Shanxi Medical University, Shanxi, China.
Feng X; Department of Neurosurgery, Beijing Hospital, Graduate School of Peking Union Medical College, Beijing, China.
Wu Z; Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Wang D; Department of Neurosurgery, Beijing Hospital, Graduate School of Peking Union Medical College, Beijing, China.
Liu A; Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; Pokaż więcej
Źródło :: Frontiers in neurology [Front Neurol] 2021 Feb 12; Vol. 12, pp. 613785. Date of Electronic Publication: 2021 Feb 12 (Print Publication: 2021).
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: Safety and Efficacy of Tirofiban for Acute Ischemic Stroke Patients With Large Artery Atherosclerosis Stroke Etiology Undergoing Endovascular Therapy.
Autorzy :: Huo X; Neurointervention Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Raynald; Neurointervention Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Wang A; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; China National Clinical Research Center for Neurological Diseases, Beijing, China.; Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China.
Mo D; Neurointervention Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Gao F; Neurointervention Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Ma N; Neurointervention Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Wang Y; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; China National Clinical Research Center for Neurological Diseases, Beijing, China.; Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China.
Wang Y; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; China National Clinical Research Center for Neurological Diseases, Beijing, China.; Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China.
Miao Z; Neurointervention Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; Pokaż więcej
Źródło :: Frontiers in neurology [Front Neurol] 2021 Feb 11; Vol. 12, pp. 630301. Date of Electronic Publication: 2021 Feb 11 (Print Publication: 2021).
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: The Pin1-CaMKII-AMPA Receptor Axis Regulates Epileptic Susceptibility.
Autorzy :: Hou X; Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, 350108, China.; Fuzhou Children's Hospital of Fujian Medical University, Fuzhou, Fujian, 350005, China.
Yang F; Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, 350108, China.
Li A; Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, 350108, China.
Zhao D; Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, 350108, China.
Ma N; Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, 350108, China.
Chen L; Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, 350108, China.; The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, 350009, China.
Lin S; Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, 350108, China.
Lin Y; The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, 350009, China.
Wang L; Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, 350108, China.
Yan X; Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, 350108, China.
Zheng M; Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, 350108, China.
Lee TH; Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, 350108, China.
Zhou XZ; Division of Translational Therapeutics, Department of Medicine and Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02115, USA.
Lu KP; Division of Translational Therapeutics, Department of Medicine and Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02115, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.
Liu H; Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, 350108, China.; Pokaż więcej
Źródło :: Cerebral cortex (New York, N.Y. : 1991) [Cereb Cortex] 2021 Feb 11. Date of Electronic Publication: 2021 Feb 11.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Knockdown of lncRNA SNHG4 suppresses gastric cancer cell proliferation and metastasis by targeting miR-204-5p.
Autorzy :: Cheng XB; Department of Gastrointestinal Colorectal and Anal Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Zhang T; School of Pharmaceutical Sciences, Changchun University of Chinese Medicine, Changchun, Jilin, China.
Zhu HJ; Department of Pediatric Ultrasound, The First Hospital of Jilin University, Changchun, Jilin, China.
Ma N; Department of hepatopancreatobiliary surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Sun XD; Department of Second Gynecologic Oncology Surgery, Jilin Cancer Hospital, Changchun, Jilin, China.
Wang SH; Department of Abdominal Oncology Surgery, Jilin Cancer Hospital, Changchun, Jilin, China.
Jiang Y; Department of Gastrointestinal Colorectal and Anal Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.; Pokaż więcej
Źródło :: Neoplasma [Neoplasma] 2021 Feb 11. Date of Electronic Publication: 2021 Feb 11.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: circTulp4 functions in Alzheimer's disease pathogenesis by regulating its parental gene, Tulp4.
Autorzy :: Ma N; Greater Bay Biomedical Innocenter, Shenzhen Bay Laboratory, Shenzhen, Guangdong Province, China; Shenzhen Key Laboratory for Neuronal Structural Biology, Biomedical Research Institute, Shenzhen Peking University - The Hong Kong University of Science and Technology Medical Center, Shenzhen, Guangdong Province, China; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Beijing, China.
Pan J; Greater Bay Biomedical Innocenter, Shenzhen Bay Laboratory, Shenzhen, Guangdong Province, China; Shenzhen Key Laboratory for Neuronal Structural Biology, Biomedical Research Institute, Shenzhen Peking University - The Hong Kong University of Science and Technology Medical Center, Shenzhen, Guangdong Province, China.
Wen Y; Department of Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, Guangdong Province, China.
Wu Q; Greater Bay Biomedical Innocenter, Shenzhen Bay Laboratory, Shenzhen, Guangdong Province, China.
Yu B; Shenzhen Key Laboratory for Translational Medicine of Dermatology, Biomedical Research Institute, Shenzhen Peking University - The Hong Kong University of Science and Technology Medical Center, Shenzhen, Guangdong Province, China; Department of Dermatology, Peking University Shenzhen Hospital, Shenzhen, Guangdong Province, China.
Chen X; Department of Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, Guangdong Province, China.
Wan J; Greater Bay Biomedical Innocenter, Shenzhen Bay Laboratory, Shenzhen, Guangdong Province, China; Shenzhen Key Laboratory for Neuronal Structural Biology, Biomedical Research Institute, Shenzhen Peking University - The Hong Kong University of Science and Technology Medical Center, Shenzhen, Guangdong Province, China; Department of Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, Guangdong Province, China. Electronic address: .
Zhang W; Greater Bay Biomedical Innocenter, Shenzhen Bay Laboratory, Shenzhen, Guangdong Province, China; Shenzhen Key Laboratory for Neuronal Structural Biology, Biomedical Research Institute, Shenzhen Peking University - The Hong Kong University of Science and Technology Medical Center, Shenzhen, Guangdong Province, China. Electronic address: .; Pokaż więcej
Źródło :: Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2021 Feb 10. Date of Electronic Publication: 2021 Feb 10.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Ma N"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język